Baidu CEO Robin Li's AI Life Sciences Company Reportedly Plans Hong Kong IPO
Baidu
An AI life sciences company founded by Baidu CEO Robin Li is reportedly planning an IPO in Hong Kong. The company focuses on using artificial intelligence for drug discovery and development.
According to reports, an AI life sciences company spearheaded by Baidu CEO Robin Li is considering an initial public offering in Hong Kong. The company, which leverages artificial intelligence for drug discovery and development, has not yet confirmed the IPO plans. The news was first reported by Chinese media outlet Yicai, citing unnamed sources. The company is believed to be valued at several billion dollars and could become one of the few AI-driven biotech firms to list in Hong Kong.
- Сокращения
- IPO = Initial Public Offering — первичное публичное размещение акций
Source: Baidu ERNIE (GNews) —
original